RETRACTION: LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p (Retraction of Vol 13, Pg 4393, 2021)

被引：0
|
作者：
Han, X.
Liu, J.
Liu, Y.
Mou, L.
Li, C.
机构：
来源：
CANCER MANAGEMENT AND RESEARCH | 2023年 / 15卷
关键词：
D O I：
10.2147/CMAR.S448606
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1267 / 1267
页数：1
相关论文
共 50 条
  • [31] RETRACTION: microRNA-125b inhibits cell migration and invasion by targeting matrix metallopeptidase 13 in bladder cancer (vol 5, pg 829, 2013) (Retraction of Vol 5, Pg 829, 2013)
    Wu, Deyao
    Ding, Jingjing
    Wang, Linmao
    Pan, Huixing
    Zho, Zhengdong
    Zhou, Jian
    Qu, Ping
    ONCOLOGY LETTERS, 2022, 24 (05)
  • [32] MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2
    Wu, Meng
    Duan, Qingyun
    Liu, Xue
    Zhang, Ping
    Fu, Yu
    Zhang, Zhenxing
    Liu, Laikui
    Cheng, Jie
    Jiang, Hongbing
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 122
  • [33] RETRACTION: LINC00346 accelerates the malignant progression of colorectal cancer via competitively binding to miRNA-101-5p/MMP9 (Retraction of Vol 24, Pg 6639, 2020)
    Tong, W. -H.
    Mu, J. -F.
    Zhang, S. -P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (09) : 3398 - 3398
  • [34] LncRNA LINC-PINT increases SOCS1 expression by sponging miR-155-5p to inhibit the activation of ERK signaling pathway in rheumatoid arthritis synovial fibroblasts induced by TNF-α
    Wang, Jing
    Zhao, Qing
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 84
  • [35] RETRACTION: Long noncoding RNA LINC00460 promotes the progression of cervical cancer via regulation of the miR-361-3p/Gli1 axis (Retraction of Vol 34, Pg 229, 2021)
    Li, Fan
    Zhu, Weipei
    Wang, Zhijie
    HUMAN CELL, 2022, 35 (04) : 1306 - 1306
  • [36] RETRACTION: Circ_0069718 promotes the progression of breast cancer by up-regulating NFIB through sequestering miR-590-5p (Retraction of Vol 32, Pg 517, 2021)
    Zhao, Yongsheng
    Ma, Xiaocha
    Shi, Weihua
    MAMMALIAN GENOME, 2023, 34 (SUPPL 1) : S2 - S2
  • [37] RETRACTION: MiR-338-5p ameliorates pathological cardiac hypertrophy by targeting CAMKIIδ (Retraction of Vol 42, Pg 1071, 2019)
    Li, Kailong
    Lin, Yuedong
    Li, Cong
    ARCHIVES OF PHARMACAL RESEARCH, 2025, 48 (02) : 181 - 181
  • [38] RETRACTION: lncRNA CRNDE is Upregulated in Glioblastoma Multiforme and Facilitates Cancer Progression Through Targeting miR-337-3p and ELMOD2 Axis (Retraction of Vol 13, Pg 9225, 2020)
    Gao, J.
    Chen, Q.
    Zhao, Y.
    Hou, R.
    ONCOTARGETS AND THERAPY, 2020, 13 : 12721 - 12721
  • [39] RETRACTION: LncRNA HCP5 Promotes Cell Invasion and Migration by Sponging miR-29b-3p in Human Bladder Cancer (Retraction of Vol 13, Pg 11827, 2020)
    Zhao, C.
    Li, Y.
    Hu, X.
    ONCOTARGETS AND THERAPY, 2024, 17 : 159 - 159
  • [40] RETRACTION: Circ_0005576 Promotes Malignant Progression Through miR-874/CDK8 Axis in Colorectal Cancer (Retraction of Vol 13, Pg 7793, 2020)
    Yu, C.
    Li, S.
    Hu, X.
    ONCOTARGETS AND THERAPY, 2023, 16 : 327 - 327
12345